While the clinical effect of TDP-43 in CBD is complex and still under investigation, there is a tendency for CBD cases with severe TDP-43 pathology to be misdiagnosed with PSP compared to those with CBD with minimal or no TDP-43 [87]. This evidence concerns the gene TARDBP and supranuclear palsy, progressive, 1.